Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Paul Daru"'
Publikováno v:
Bulletin of the World Health Organization, Vol 84, Iss 6, Pp 479-484 (2006)
In 1998, the Damien Foundation Bangladesh invited semi-qualified, private "gram dakter" (Bangla for "village doctors") to participate in tuberculosis (TB) programmes in a population of 26 million people in rural Bangladesh. The organization trained 1
Externí odkaz:
https://doaj.org/article/4d71382bfa0b40f6b7301ba7873acef5
Autor:
Edward A. Nardell, Shirajul Islam, Shelley Hurwitz, Amy Elizabeth Barrera, Ruvandhi R. Nathavitharana, Mostafizur Rahman, Md. Shamim Hossain, Philip Lederer, S.M. Mostofa Kamal, Neeraj Kak, Razia Sultana, Dylan B. Tierney, Paul Daru, Manjur ul-Alam, Krishnapada Chakraborty
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 21:1020-1025
SETTING National Institute of Diseases of the Chest and Hospital, Dhaka; Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders, Dhaka; and Chittagong Chest Disease Hospital, Chittagong, Bangladesh. OBJECTI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82b237fcc4f19d6075703d3bc8ca77b0
https://doi.org/10.5588/ijtld.16.0794
https://doi.org/10.5588/ijtld.16.0794
Autor:
Sayera Banu, Joan M. Mangan, Sabera Sultana, Shahriar Ahmed, Vikarunessa Begum, Ekaterina V. Kurbatova, Zinia Sultana, Paul Daru, Joseph S. Cavanaugh, Negar N. Alami, James D. Heffelfinger, Julia Ershova, Alexander Golubkov
Publikováno v:
Tropical Medicine & International Health. 21:131-139
Objective Drug-resistant tuberculosis (TB) threatens global TB control because it is difficult to diagnose and treat. Community-based programmatic management of drug-resistant TB (cPMDT) has made therapy easier for patients, but data on these models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71c7e96cb0a0fdb48bee53d3c5c15588
https://doi.org/10.1111/tmi.12625
https://doi.org/10.1111/tmi.12625
Publikováno v:
Global Health: Science and Practice
Background Bangladesh is a highly populous country where the prevalence of drug-resistant tuberculosis (DR-TB) is growing. With the rapid increase in DR-TB notifications through GeneXpert technology, it was imperative to come up with a new treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02435298e2638399216acc553e6261d8
https://pubmed.ncbi.nlm.nih.gov/30591582
https://pubmed.ncbi.nlm.nih.gov/30591582
Publikováno v:
Bulletin of the World Health Organization. 84:479-484
In 1998, the Damien Foundation Bangladesh invited semi-qualified, private "gram dakter" (Bangla for "village doctors") to participate in tuberculosis (TB) programmes in a population of 26 million people in rural Bangladesh. The organization trained 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41b8ed5678e1b7f45e4f5ac6e741b668
https://doi.org/10.2471/blt.05.023929
https://doi.org/10.2471/blt.05.023929
Autor:
Paul Daru, Hans L. Rieder, Salim Ah, Armand Van Deun, Pankaj Kumar Das, Mihir Ranjan Sarker, Aung Kya Jai Maug
RATIONALE: Based on expert opinion, the global guidelines for management of multidrug-resistant tuberculosis impose lengthy and often poorly tolerated treatments. OBJECTIVES: This observational study evaluates the effectiveness of standardized regime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24a0aca568b42cc916016b690452f2c0
https://www.zora.uzh.ch/id/eprint/42091/
https://www.zora.uzh.ch/id/eprint/42091/
